G. Ishdorj

发表

Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells

S. Gibson, J. Johnston, Ju-Yoon Yoon, 2013, Apoptosis.

Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B

S. Gibson, J. Johnston, D. Szwajcer, 2013, Blood Cancer Journal.

Regulation of autophagy in hematological malignancies: role of reactive oxygen species

Lin Li, S. Gibson, G. Ishdorj, 2012, Leukemia & lymphoma.

IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.

S. Gibson, J. Johnston, A. Marshall, 2019, Blood advances.

Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment

S. Gibson, Xiaojie Hu, G. Ishdorj, 2008, Apoptosis.

The Rat Leukocyte-type 12-Lipoxygenase Exhibits an Intrinsic Hepoxilin A3 Synthase Activity*

J. Haeggström, S. Nigam, R. Ciccoli, 2004, Journal of Biological Chemistry.

Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses

S. Gibson, J. Johnston, G. Ishdorj, 2011, Leukemia & lymphoma.

Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival

S. Gibson, J. Johnston, Z. Nugent, 2019, Leukemia & lymphoma.

Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoids.

S. Sahi, S. Nigam, R. Ciccoli, 2005, The Biochemical journal.

Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment.

Lin Li, S. Gibson, G. Ishdorj, 2012, Free radical biology & medicine.

Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence.

J. Hacker, C. Lan, G. Köhler, 2006, International journal of medical microbiology : IJMM.

Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC*

S. Gibson, X. Fang, J. Johnston, 2008, Journal of Biological Chemistry.

Epigenetic inactivation of TRAIL decoy receptors at 8p12‐21.3 commonly deleted region confers sensitivity to Apo2L/trail‐Cisplatin combination therapy in cervical cancer

M. Mansukhani, A. Kaufmann, V. Murty, 2016, Genes, chromosomes & cancer.

A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia.

S. Gibson, J. Johnston, S. Kost, 2017, Leukemia research.

Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis

S. Gibson, J. Johnston, G. Ishdorj, 2010, Molecular Cancer Therapeutics.

Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B Leukemic Cells

S. Gibson, J. Johnston, G. Ishdorj, 2011, BMC Cancer.

Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells

S. Gibson, J. Johnston, Ju-Yoon Yoon, 2013, Apoptosis.

PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis

B. Tycko, G. Bhagat, L. Clark, 2013, Genes, chromosomes & cancer.

Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines.

S. Gibson, J. Johnston, Z. Nugent, 2021, Leukemia research.